Clinical Trials in Georgia

Showing 141-160 of 19,050 trials

Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).

NCT07264517

This is a Phase 2, multi-site, double-masked, randomized, vehicle-controlled, study designed to evaluate the safety, tolerability, and efficacy in adult participants with DED.

Dry Eye Disease

Instituto Grifols, S.A.103 participantsStarted Nov 2025

Glendale, California, United States • Grove, California, United States • Newport Beach, California, United States +7 more locations

Active Not RecruitingNA65 miles

TECTONIC CAD IVL IDE Study

NCT06885177

A prospective, single-arm, open-label, multi-center IDE study with up to 55 US sites

Coronary Artery CalcificationCoronary Artery DiseaseStenotic Coronary Lesion

Abbott Medical Devices335 participantsStarted Apr 2025

Scottsdale, Arizona, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +37 more locations

Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).

TECTONIC CAD IVL IDE Study

Find Trials by Condition in Georgia

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

Nivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Undergoing Surgery

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

Study of Oral Atogepant When Added to OnabotulinumtoxinA (BOTOX) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Chronic Migraine

Radiation Free Study

A Study of Durvalumab (MEDI4736) and Monalizumab in Solid Tumors

Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

Clinical Procedures to Support Research in ALS

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Excimer Laser Trabeculostomy Glaucoma Treatment Study

A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function

Efficacy and Safety Study of Moxidectin in Adults With Scabies

Regorafenib and Pembrolizumab in Treating Participants With Advanced or Metastatic Colorectal Cancer

A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)